Research, Science & Development

Researchers will assess the drug’s efficacy and safety in patients with acute coronary syndrome (ACS), recent myocardial infarction, ischemic stroke, and peripheral arterial disease.

The EMA Committee for Orphan Medicinal Products supported the designation after recognising a strong unmet need in neuroendocrine carcinomas.

The development comes nearly two decades after the first human genome draft was completed in 2001 and a decade after Africa’s first human genome sequencing effort in South Africa in 2013.

The findings come from a mathematical modeling study published in Science Advances, which offers the first population-level estimates of how an HSV-1 vaccine could reshape disease trends.

Researchers found that nearly all major DNA methylation changes were associated with tau accumulation rather than amyloid plaques.

Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.

The appeal followed discussions held during the 79th World Health Assembly (WHA79), where climate-related health risks featured prominently across several agenda items.

Researchers tested the therapy through the MATCH clinical trial, which involved 50 patients with advanced liver cirrhosis.

The company’s presentations at EASL 2026 build on results from the Phase 3 ESSENCE programme, where semaglutide 2.4 mg previously demonstrated significant reductions in liver inflammation and fibrosis among patients with MASH.

Built on the Mayo Clinic Platform, the system operates within a secure environment where Mayo Clinic teams can access large volumes of de-identified patient data.